Dr. Delphine Lee, M.D., Ph.D, focuses on the health and wellness of your skin, hair and nails. The skin is the largest and most exposed organ of the body, susceptible to infection, cancer and autoimmunity. As an expert in how the immune system functions, Dr. Lee emphasizes prevention and early diagnosis.
Dr. lectures at the Pacific Dermatologic Association's Annual meeting on "Melanoma: Staging and Diagnostics" in Coronado Island, CA on August 16, 2019.
Dr. Lee lectures at the 37th Carl M. Pearson Memorial Symposium: Frontiers of Rheumatology Conference on "The Microbiome & its Role on Immunoregulation & Psoriasis" on April 13, 2019.
Dr. Lee lectures at Institut Pasteur de Lille on "BCG as a Therapy for Inoperable Cutaneous Metastatic Melanoma" at the International BCG Symposium in Lille Cedex, France on December 5, 2018
Dr. Lee lectures at Cancer Support Community “Frankly Speaking About Cancer: Immunotherapy” on December 15, 2017
Dr. Lee interviewed by Stephanie Booth in an article from Health: "I Thought My Dark Skin Protected Me From Melanoma—I Was Wrong" , published June 27, 2017
Dr. Lee is the Director of the Dermatological Center for Skin Health with expertise in complicated skin rashes and skin cancer. She treats her private patients at St. John's Health Center in Santa Monica. She is also the Chief of Dermatology and Residency Program Director at Harbor-UCLA Medical Center in Torrance, California.
Under Dr. Lee’s direction, investigators on her team at the Los Angeles Biomedical Research Institute (LA BioMed) are respected researchers whose expertise extends well beyond cancer, allowing them to draw parallels between the inappropriate immune responses causing diseases: both cancer and non-cancerous. For example, they are comparing the immune response against skin cancer (melanoma) to the immune response seen in autoimmune skin diseases such as vitiligo and infectious skin diseases such as leprosy. A key focus of this lab is the investigation of the role of microbes in enhancing antitumor immune responses. Research involves cutting edge basic science and computational techniques to study the immune system in melanoma, breast cancer, and other malignancies.